Odigyn Fertility Care And Hospitals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-06-2024
- Paid Up Capital ₹ 3.00 M
as on 17-06-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 Cr
as on 17-06-2024
- Revenue %
(FY 2023)
- Profit -3194.08%
(FY 2023)
- Ebitda -1233.93%
(FY 2023)
- Net Worth 4125.46%
(FY 2023)
- Total Assets 11463.99%
(FY 2023)
About Odigyn Fertility Care And Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.20 Cr.
Sanjaya Mishra, Phalguni Patro, and Surendra Mohanty serve as directors at the Company.
- CIN/LLPIN
U85310OR2019PTC031997
- Company No.
031997
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Cuttack, Orissa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Odigyn Fertility Care And Hospitals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Mohanty  | Director | 07-Nov-2019 | Current |
| Sanjaya Mishra | Director | 07-Nov-2019 | Current |
| Phalguni Patro | Director | 07-Nov-2019 | Current |
Financial Performance of Odigyn Fertility Care And Hospitals.
Odigyn Fertility Care And Hospitals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 3194.08% decrease in profit. The company's net worth Soared by an impressive increase of 4125.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Odigyn Fertility Care And Hospitals?
In 2023, Odigyn Fertility Care And Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Odigyn Ivf Centre Private LimitedActive 5 monthsSanjaya Mishra, Phalguni Patro and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 24 Jan 2023 | ₹1.20 Cr | Open |
How Many Employees Work at Odigyn Fertility Care And Hospitals?
Unlock and access historical data on people associated with Odigyn Fertility Care And Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Odigyn Fertility Care And Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Odigyn Fertility Care And Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
